Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway
Author:
Funder
Scientific and Technological Research Council of Turkey
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference63 articles.
1. Cancer statistics;Siegel;CA Cancer J. Clin.,2013
2. Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: a systematic review of randomised trials;West;Eur. J. Cancer,2014
3. The development of androgen-independent prostate cancer;Feldman;Nat. Rev. Cancer,2001
4. Stem cells, cancer, and cancer stem cells;Reya;Nature,2001
5. Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention;Gasch;Mol. Cancer,2017
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action;International Journal of Molecular Sciences;2024-09-04
2. A comprehensive review on the use of traditional Chinese medicine for cancer treatment;Pharmacological Research - Modern Chinese Medicine;2024-06
3. Bioactive compounds from nature: Antioxidants targeting cellular transformation in response to epigenetic perturbations induced by oxidative stress;Biomedicine & Pharmacotherapy;2024-05
4. Multifaceted impact of adipose conditioned media: Obesity‐driven promotion of prostate cancer and cancer stem cell dynamics;Cell Biochemistry and Function;2024-03
5. Novel Midkine Inhibitor Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma;Anticancer Research;2024-02-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3